Literature DB >> 6339023

A guide to the pharmacology of placebos.

C W Gowdey.   

Abstract

The placebo effect is capable of relieving pain in a substantial proportion of patients; affective disorders also respond to the administration of inert medication. Changes in objective measures, such as blood pressure and blood glucose levels, demonstrate the action of placebos. The underlying mechanisms are not yet known, but because the nature and strength of the placebo response are governed by the patient's perceptions, both positive and negative results may be obtained. The complexity of human perception has made it extremely difficult to characterize the people who react. In clinical situations the placebo may be underused as a therapeutic agent, while in clinical trials the effect may be inadequately evaluated; the power and nature of the placebo effect truly warrant greater recognition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339023      PMCID: PMC1875414     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  51 in total

1.  Ethics and practice of placebo therapy.

Authors:  A LESLIE
Journal:  Am J Med       Date:  1954-06       Impact factor: 4.965

2.  A method for the determination of the effects of drugs on the pain threshold of human subjects.

Authors:  G A DENEAU; R A WAUD; C W GOWDEY
Journal:  Can J Med Sci       Date:  1953-10

3.  The placebo as a source of side effects in normal people: influence of gradually increasing doses.

Authors:  R C POGGE; E A COATS
Journal:  Nebr State Med J       Date:  1962-06

4.  The assessment of cough suppressing drugs.

Authors:  B R HILLIS
Journal:  Lancet       Date:  1952-06-21       Impact factor: 79.321

5.  Clonidine prophylaxis of childhood migraine and other vascular headache. A double blind study of 57 children;.

Authors:  M Sillanpää
Journal:  Headache       Date:  1977-03       Impact factor: 5.887

6.  The doctor-patient relationship and drug effect.

Authors:  J Freund; G Krupp; D Goodenough; L W Preston
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

7.  A controlled clinical trial using placebos in normal subjects: a teaching exercise.

Authors:  C W Gowdey; J T Hamilton; R B Philp
Journal:  Can Med Assoc J       Date:  1967-05-13       Impact factor: 8.262

8.  Some comments on non-drug factors in psychiatric drug therapy.

Authors:  K Rickels
Journal:  Psychosomatics       Date:  1965 Sep-Oct       Impact factor: 2.386

9.  Zomepirac sodium in the treatment of primary dysmenorrhea syndrome.

Authors:  P W Budoff
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

10.  Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts.

Authors:  L LASAGNA; J M VON FELSINGER; H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-03-19
View more
  5 in total

Review 1.  [Dose-response relation: relevance for clinical practice].

Authors:  U Klinkhardt; S Harder
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Dose-finding studies in clinical drug development.

Authors:  R Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Effect of metformin glycinate on glycated hemoglobin A1C concentration and insulin sensitivity in drug-naive adult patients with type 2 diabetes mellitus.

Authors:  Manuel González-Ortiz; Esperanza Martínez-Abundis; José A Robles-Cervantes; Maria G Ramos-Zavala; Carmelita Barrera-Durán; Jorge González-Canudas
Journal:  Diabetes Technol Ther       Date:  2012-09-13       Impact factor: 6.118

4.  Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years.

Authors:  C W Gowdey; M Brennan
Journal:  Can Med Assoc J       Date:  1985-01-01       Impact factor: 8.262

5.  Comparison of Placebo Effect between Asian and Caucasian Type 2 Diabetic Patients: A Meta-Analysis.

Authors:  Wei Guo; Lin Nie; Xi-Rui Wang; Mei-Ling Xu; Wen-Jia Yang; Xue-Ying Gao; Xiao-Ling Cai; Li-Nong Ji
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.